WHITE PLAGUE Rebounds

A patient lying in a hospital bed with a monitoring device in hand — WHITE PLAGUE LOOMS!

The “white plague” is quietly rebounding in America—and the most hard-nosed part is that the real driver isn’t politics, it’s missed detection and weak follow-through in the places our institutions already struggle to manage.

Story Snapshot

CDC-tracked tuberculosis cases rose to 10,388 in 2024, the highest U.S. count since 2011, after decades of decline.
Health officials and researchers tie the rebound to post-COVID disruptions, international travel and migration patterns, and localized outbreaks.
TB spreads through the air and can stay “latent,” meaning people can carry it without symptoms until it activates.
Hot spots and high-risk settings include certain states with outbreaks, and congregate environments like jails and prisons.

What the 2024 TB numbers actually show

CDC-related reporting finalized the U.S. total at 10,388 tuberculosis cases in 2024, up about 8% from 2023 and the highest count since 2011. The increase was broad, with more than 30 states, plus Washington, D.C., reporting higher numbers.

State-level signals varied: Alaska and Hawaii had the highest rates, while Kansas posted a sharp percentage jump tied to an outbreak rather than a gradual trend.

'White plague' is on the rise in the US – it's deadlier than Covid and becoming antibiotic resistant https://t.co/RbrjT2kbyJ pic.twitter.com/nD0UC5lwm8

— New York Post (@nypost) March 25, 2026

The key point for readers is that TB’s rise does not mean the disease is “new,” but it does signal that America’s long-running progress has stalled. Before 2020, U.S. TB had been declining for nearly three decades.

Pandemic-era disruptions then created a gap—fewer screenings, missed diagnoses, delayed treatment—and once travel and normal movement resumed, the pipeline of detection and follow-up did not fully catch up.

Why TB is hard to control: airborne spread and latent infection

Tuberculosis is caused by Mycobacterium tuberculosis and typically attacks the lungs, spreading through the air when an infected person coughs or sneezes.

Unlike many headline diseases, TB can remain latent, meaning someone may not feel sick and still carry the bacteria. That combination—airborne transmission plus hidden carriage—makes consistent screening and treatment completion the make-or-break issue for public health departments.

The treatment challenge is also structural. Standard TB therapy can require multiple antibiotics over months, and public health success depends on patients finishing the full regimen.

Researchers and public health officials warn that long, difficult courses can contribute to drug resistance when treatment is incomplete or inconsistent.

The research noted multidrug-resistant TB as a concern, but the available U.S.-specific details in the source set do not quantify the extent of resistance in the U.S. right now.

Migration, travel, and the policy problem no one wants to say plainly

Health reporting summarized in the research links the rebound to international travel and migration patterns, as well as outbreaks and pandemic-era disruptions.

The data cited in the background shows TB burden is far higher among foreign-born residents than U.S.-born residents, which is consistent with long-standing CDC patterns: TB is concentrated where screening is uneven and where people arrive from higher-incidence regions.

That does not justify smearing immigrants; it does demand serious, lawful, properly funded entry screening and follow-up.

For a conservative audience that’s tired of bureaucratic failure, the frustration is predictable: federal and state systems often find money for “awareness” campaigns while leaving basic public health execution uneven—testing, contact tracing for TB exposure, and ensuring people complete treatment.

The constitutional concern is not about forced medicine; it’s about government competence and transparency. If officials cannot track, test, and treat effectively, they will inevitably turn to broader mandates that punish compliant citizens instead.

Where TB hits hardest: prisons, poverty, and weak primary care access

Experts cited in the research flag congregate settings, including jails and prisons, as high-risk environments for TB transmission. Overcrowding and limited healthcare access allow airborne diseases to spread and linger.

The wider Americas picture adds context: PAHO reported hundreds of thousands of TB illnesses region-wide, with a substantial share undiagnosed—meaning people can spread disease without ever entering a treatment pathway. That is the exact opposite of what a functioning system should tolerate.

NEWS🚨: 'White plague' is on the rise in the US – it's deadlier than Covid and becoming antibiotic resistant, says NYP pic.twitter.com/hHoZ4EHqZP

— All day Astronomy (@forallcurious) March 25, 2026

Local data show mixed movement, underscoring the importance of policy execution. New York City reported an 11% decrease in TB cases in 2025 compared with 2024, yet officials still described TB rates as elevated.

That suggests gains are possible when local public health infrastructure is focused and consistent.

However, the broader national trend remains upward, and the research emphasizes primary care access, community-based detection, and follow-through as central tools for reversing it.